Citadel Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.28M | Buy |
285,007
+175,852
| +161% | +$3.06M | ﹤0.01% | 3973 |
|
|
2025
Q4 | $1.29M | Buy |
+109,155
| New | +$1.4M | ﹤0.01% | 6854 |
|
|
2025
Q2 | – | Sell |
-651,028
| Closed | -$7.34M | – | 12720 |
|
|
2025
Q1 | $8.81M | Buy |
651,028
+375,187
| +136% | +$6.23M | ﹤0.01% | 3025 |
|
|
2024
Q4 | $4.66M | Buy |
275,841
+24,186
| +10% | +$471K | ﹤0.01% | 4074 |
|
|
2024
Q3 | $5.11M | Buy |
251,655
+162,813
| +183% | +$3.33M | ﹤0.01% | 3898 |
|
|
2024
Q2 | $2.01M | Buy |
88,842
+72,241
| +435% | +$1.89M | ﹤0.01% | 5308 |
|
|
2024
Q1 | $436K | Sell |
16,601
-940,250
| -98% | -$26.8M | ﹤0.01% | 8685 |
|
|
2023
Q4 | $30.2M | Buy |
956,851
+78,199
| +9% | +$2.12M | 0.01% | 1616 |
|
|
2023
Q3 | $24.6M | Sell |
878,652
-942,751
| -52% | -$32.4M | 0.01% | 1656 |
|
|
2023
Q2 | $67.2M | Buy |
1,821,403
+1,655,823
| +1,000% | +$50.5M | 0.01% | 836 |
|
|
2023
Q1 | $4.96M | Buy |
165,580
+149,807
| +950% | +$4.93M | ﹤0.01% | 3832 |
|
|
2022
Q4 | $483K | Sell |
15,773
-774,792
| -98% | -$23.2M | ﹤0.01% | 8310 |
|
|
2022
Q3 | $19.5M | Sell |
790,565
-2,361
| -0.3% | -$77.9K | ﹤0.01% | 1898 |
|
|
2022
Q2 | $25.4M | Buy |
792,926
+553,869
| +232% | +$20.4M | 0.01% | 1604 |
|
|
2022
Q1 | $7.53M | Buy |
239,057
+197,328
| +473% | +$6.17M | ﹤0.01% | 3432 |
|
|
2021
Q4 | $1.4M | Sell |
41,729
-393,654
| -90% | -$12.3M | ﹤0.01% | 7051 |
|
|
2021
Q3 | $12.7M | Buy |
435,383
+96,593
| +29% | +$3.13M | ﹤0.01% | 2668 |
|
|
2021
Q2 | $11.8M | Buy |
338,790
+174,348
| +106% | +$5.77M | ﹤0.01% | 2826 |
|
|
2021
Q1 | $4.59M | Sell |
164,442
-158,238
| -49% | -$4.21M | ﹤0.01% | 4438 |
|
|
2020
Q4 | $8M | Sell |
322,680
-1,261,661
| -80% | -$30M | ﹤0.01% | 2942 |
|
|
2020
Q3 | $33.1M | Buy |
1,584,341
+1,113,792
| +237% | +$21.5M | 0.01% | 1140 |
|
|
2020
Q2 | $7.22M | Sell |
470,549
-742,238
| -61% | -$9.38M | ﹤0.01% | 2597 |
|
|
2020
Q1 | $10.8M | Buy |
1,212,787
+1,142,084
| +1,615% | +$16.5M | ﹤0.01% | 1775 |
|
|
2019
Q4 | $1.28M | Sell |
70,703
-192,966
| -73% | -$3.2M | ﹤0.01% | 5156 |
|
|
2019
Q3 | $3.94M | Sell |
263,669
-495,682
| -65% | -$8.06M | ﹤0.01% | 3445 |
|
|
2019
Q2 | $18.2M | Buy |
759,351
+554,317
| +270% | +$16.3M | 0.01% | 1504 |
|
|
2019
Q1 | $7.62M | Buy |
205,034
+151,269
| +281% | +$5.5M | ﹤0.01% | 2402 |
|
|
2018
Q4 | $1.52M | Sell |
53,765
-807,753
| -94% | -$25.6M | ﹤0.01% | 4606 |
|
|
2018
Q3 | $34M | Buy |
861,518
+714,592
| +486% | +$31.3M | 0.02% | 997 |
|
|
2018
Q2 | $6.52M | Buy |
146,926
+79,838
| +119% | +$3.97M | ﹤0.01% | 2425 |
|
|
2018
Q1 | $3.27M | Sell |
67,088
-534,514
| -89% | -$26.7M | ﹤0.01% | 3025 |
|
|
2017
Q4 | $30.1M | Sell |
601,602
-288,971
| -32% | -$15.1M | 0.02% | 909 |
|
|
2017
Q3 | $45.1M | Buy |
890,573
+105,632
| +13% | +$4.98M | 0.03% | 606 |
|
|
2017
Q2 | $29.8M | Buy |
784,941
+107,925
| +16% | +$4.26M | 0.03% | 760 |
|
|
2017
Q1 | $26.1M | Buy |
677,016
+601,299
| +794% | +$18.1M | 0.02% | 791 |
|
|
2016
Q4 | $1.67M | Buy |
+75,717
| New | +$1.55M | ﹤0.01% | 3169 |
|
|
2016
Q3 | – | Sell |
-51,465
| Closed | -$588K | – | 7255 |
|
|
2016
Q2 | $424K | Sell |
51,465
-127,381
| -71% | -$1.13M | ﹤0.01% | 4717 |
|
|
2016
Q1 | $1.25M | Sell |
178,846
-147,253
| -45% | -$740K | ﹤0.01% | 3205 |
|
|
2015
Q4 | $1.75M | Sell |
326,099
-565,081
| -63% | -$3.61M | ﹤0.01% | 2879 |
|
|
2015
Q3 | $5.77M | Buy |
+891,180
| New | +$9.33M | 0.01% | 1809 |
|
Other funds holding CC
VPM
VCM
WHCM
Citadel Advisors's CC Position: Q1 2026 in Review
Citadel Advisors increased its Chemours (CC) stake by 161% in Q1 2026, buying an estimated $3.06M and bringing the position to 285,007 shares worth $6.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3973.
Citadel Advisors first reported a position in CC in Q3 2015 and has held it in 40 quarters since. The position peaked at $67.2M in Q2 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- Citadel Advisors held 285,007 shares of Chemours worth $6.28M as of Q1 2026.
- Citadel Advisors bought 175,852 Chemours shares in Q1 2026, an estimated $3.06M.
- Chemours made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3973 holding.
- Citadel Advisors first reported a position in Chemours in Q3 2015 and has held it in 40 quarters since.
- Citadel Advisors's Chemours position peaked at $67.2M in Q2 2023.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.